BioNexus Gene Lab Corp.
BGLC
Rank in Stocks
#32058
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Share Price
$0.8589
Last synced: 2026-11-11
Market Cap
$2.08M
Change (1 day)
4.74%
Change (1 year)
-82.25%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioNexus Gene Lab Corp. (BGLC)
Category
Industrials
Operating Margin for BioNexus Gene Lab Corp. (BGLC)
Operating Margin as of November 2026 TTM: -82.78%
According to BioNexus Gene Lab Corp.'s latest financial reports, its current operating margin (TTM) is -82.78%. At the end of 2025 the company had an operating margin of -42.54%.
Operating Margin history for BioNexus Gene Lab Corp. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -82.78% | 94.59% |
| 2025 | -42.54% | 157.04% |
| 2024 | -16.55% | -37.64% |
| 2023 | -26.54% | 897.74% |
| 2022 | -2.66% | -133.67% |
| 2021 | 7.90% | -29.34% |
| 2020 | 11.18% | -105.15% |
| 2019 | -217.17% | -869.83% |
| 2018 | 28.21% | -123.75% |
| 2017 | -118.79% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.57% | -100.18% |
US
|
|
| 20.54% | -100.25% |
US
|
|
| 9.01% | -100.11% |
US
|
|
| 5.57% | -100.07% |
US
|
|
| -2.27% | -99.97% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BioNexus Gene Lab Corp.'s operating margin
What is BioNexus Gene Lab Corp.'s operating margin?
BioNexus Gene Lab Corp.'s operating margin is -82.78%, as of Nov 2026.
What was BioNexus Gene Lab Corp.'s operating margin in 2025?
In 2025, BioNexus Gene Lab Corp.'s operating margin was -42.54%, compared with -16.55% in 2024.
How has BioNexus Gene Lab Corp.'s operating margin changed since 2020?
From 2020 to 2025, BioNexus Gene Lab Corp.'s operating margin was highest in 2020 (11.18%) and lowest in 2025 (-42.54%).
How does BioNexus Gene Lab Corp.'s operating margin compare with similar companies?
BioNexus Gene Lab Corp.'s operating margin (-82.78%) is lower than that of all 5 similar companies listed above. The highest among them is Fastenal Company, with 20.54%.